BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36384737)

  • 1. Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
    Schepens EJA; Blijleven EE; Boek WM; Boesveldt S; Stokroos RJ; Stegeman I; Kamalski DMA
    BMC Med; 2022 Nov; 20(1):445. PubMed ID: 36384737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year psychophysical evaluation of COVID-19-induced olfactory disorders: a prospective cohort study.
    Schepens EJA; Boek WM; Boesveldt S; Stokroos RJ; Stegeman I; Kamalski DMA
    BMC Med; 2023 Dec; 21(1):490. PubMed ID: 38066629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COCOS trial:
    Schepens EJA; Boek WM; Boesveldt S; Stegeman I; Stokroos RJ; Kamalski DMA
    BMJ Open; 2022 Aug; 12(8):e060416. PubMed ID: 35948382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
    Di Stadio A; Gallina S; Cocuzza S; De Luca P; Ingrassia A; Oliva S; Sireci F; Camaioni A; Ferreli F; Mercante G; Gaino F; Pace GM; La Mantia I; Brenner MJ
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4949-4961. PubMed ID: 37380908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.
    Di Stadio A; D'Ascanio L; Vaira LA; Cantone E; De Luca P; Cingolani C; Motta G; De Riu G; Vitelli F; Spriano G; De Vincentiis M; Camaioni A; La Mantia I; Ferreli F; Brenner MJ
    Curr Neuropharmacol; 2022; 20(10):2001-2012. PubMed ID: 35450527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
    Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM
    Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
    D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a double-blind randomized trial.
    Figueiredo LP; Paim PVDSL; Cerqueira-Silva T; Barreto CC; Lessa MM
    Braz J Otorhinolaryngol; 2024; 90(1):101356. PubMed ID: 37944311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial.
    Mahadev A; Hentati F; Miller B; Bao J; Perrin A; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1111-1119. PubMed ID: 37733356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
    Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?
    Vandersteen C; Payne M; Dumas LÉ; Plonka A; D'Andréa G; Chirio D; Demonchy É; Risso K; Robert P; Fernandez X; Askenazy-Gittard F; Savoldelli C; Guevara N; Castillo L; Manera V; Gros A
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3477-3484. PubMed ID: 34716806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013877. PubMed ID: 34291812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.
    Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction: A Controlled Study.
    Lechien JR; Saussez S; Vaira LA; De Riu G; Boscolo-Rizzo P; Tirelli G; Michel J; Radulesco T
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):84-91. PubMed ID: 37522295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Sodium Gluconate on Decreasing Elevated Nasal Calcium and Improving Olfactory Function Post COVID-19 Infection.
    Abdelazim MH; Abdelazim AH
    Am J Rhinol Allergy; 2022 Nov; 36(6):841-848. PubMed ID: 35942688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Prognostic, and Predictive Value of Olfactory Dysfunction for COVID-19: A Prospective Controlled Study.
    Kavaz E; Tahir E; Kurnaz SÇ; Deveci A; Tanyel EA
    Otolaryngol Head Neck Surg; 2022 Jul; 167(1):187-196. PubMed ID: 34726987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra Nasal Use of Ethylene Diamine Tetra Acetic Acid for Improving Olfactory Dysfunction Post COVID-19.
    Abdelazim MH; Mandour Z; Abdelazim AH; Ismaiel WF; Gamal M; Abourehab MAS; Alghamdi S; Alghamdi MA; Alrugi RR; Alharthi RR
    Am J Rhinol Allergy; 2023 Nov; 37(6):630-637. PubMed ID: 37786364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of Sniffin' Sticks olfactory psychophysical measurements].
    Yang L; Wei YX; Ren YY; Yu D; Sun YX; Yang BB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 48(9):741-5. PubMed ID: 24330876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.